+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | SARS-CoV Nucleocapsid |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | E. coli |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Liquid |
Purity | > 95% (10% PAGE, Coomassie staining) |
Purification | GS-4B Sepharose-Affinity Purification |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P59595 (UniProt, ExPASy) |
UniProt Secondary AC | Q7T3Z4, Q7TA14, Q7TF99, Q80E50 |
UniProt Entry Name | NCAP_CVHSA |
Gene Symbol | N |
GeneID | 1489678 |
KEGG | vg:1489678 |
Molecular Weight | 31.7 kDa. May appear as multiple bands on SDS-PAGE (intact protein at 31.7 kDa, GST fusion protein at 26 kDa and the Nucleocapsid fragment at 5.7 kDa) |
Sequence Fragment | 340-390 AA. Contains the Nucleocapsid protein immunodominant region. |
Tag | GST tag |
Buffer | 50 mM Tris-HCl, pH 8.0, containing 60 mM NaCl and 50% Glycerol. Does not contain preservatives. |
Specificity | Immunoreactive with SARS positive sera. |
Concentration | 1 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |